NO303926B1 - Anvendelse av imidazol-l-yl-forbindelser for fremstilling av farmas°ytiske preparater - Google Patents

Anvendelse av imidazol-l-yl-forbindelser for fremstilling av farmas°ytiske preparater

Info

Publication number
NO303926B1
NO303926B1 NO934090A NO934090A NO303926B1 NO 303926 B1 NO303926 B1 NO 303926B1 NO 934090 A NO934090 A NO 934090A NO 934090 A NO934090 A NO 934090A NO 303926 B1 NO303926 B1 NO 303926B1
Authority
NO
Norway
Prior art keywords
imidazol
compounds
preparation
pharmaceutical preparations
anomalies
Prior art date
Application number
NO934090A
Other languages
English (en)
Norwegian (no)
Other versions
NO934090L (fr
NO934090D0 (no
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO934090D0 publication Critical patent/NO934090D0/no
Publication of NO934090L publication Critical patent/NO934090L/no
Publication of NO303926B1 publication Critical patent/NO303926B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO934090A 1992-11-14 1993-11-12 Anvendelse av imidazol-l-yl-forbindelser for fremstilling av farmas°ytiske preparater NO303926B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO934090D0 NO934090D0 (no) 1993-11-12
NO934090L NO934090L (fr) 1994-05-16
NO303926B1 true NO303926B1 (no) 1998-09-28

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934090A NO303926B1 (no) 1992-11-14 1993-11-12 Anvendelse av imidazol-l-yl-forbindelser for fremstilling av farmas°ytiske preparater

Country Status (24)

Country Link
US (1) US5438068A (fr)
EP (1) EP0601345B1 (fr)
JP (1) JP3683286B2 (fr)
KR (1) KR100266715B1 (fr)
CN (1) CN1041053C (fr)
AT (1) ATE143597T1 (fr)
AU (1) AU667243B2 (fr)
CA (3) CA2504502A1 (fr)
CZ (1) CZ284154B6 (fr)
DE (2) DE4238553A1 (fr)
DK (1) DK0601345T3 (fr)
DZ (1) DZ1726A1 (fr)
ES (1) ES2092206T3 (fr)
GR (1) GR3021230T3 (fr)
HK (1) HK1006537A1 (fr)
HU (1) HU213506B (fr)
IL (1) IL107454A (fr)
MX (1) MX9307079A (fr)
NO (1) NO303926B1 (fr)
NZ (1) NZ250103A (fr)
PH (1) PH30702A (fr)
RU (1) RU2125877C1 (fr)
SK (1) SK278874B6 (fr)
ZA (1) ZA938463B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (fr) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH Dérivés 4-hydroxy de 5,6,9,10-tetrahydro-10-((2-méthyl-1h-imidazol-1-yl)méthyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (fr) * 1985-03-14 1994-07-20 Beecham Group Plc Médicaments pour le traitement de l'éméticité
EP0297651B1 (fr) * 1987-06-29 1993-11-03 Duphar International Research B.V Dérivés d'indole annulaires

Also Published As

Publication number Publication date
HUT65978A (en) 1994-08-29
IL107454A0 (en) 1994-02-27
US5438068A (en) 1995-08-01
SK123593A3 (en) 1994-09-07
NO934090L (fr) 1994-05-16
DK0601345T3 (da) 1996-11-18
ES2092206T3 (es) 1996-11-16
HK1006537A1 (en) 1999-03-05
SK278874B6 (sk) 1998-04-08
JPH06211656A (ja) 1994-08-02
CZ284154B6 (cs) 1998-08-12
CZ236593A3 (en) 1994-05-18
GR3021230T3 (en) 1997-01-31
CA2538177A1 (fr) 1994-05-15
ZA938463B (en) 1994-08-01
CA2102960C (fr) 2005-08-02
KR940010999A (ko) 1994-06-20
MX9307079A (es) 1994-05-31
JP3683286B2 (ja) 2005-08-17
HU213506B (en) 1997-07-28
NO934090D0 (no) 1993-11-12
EP0601345A1 (fr) 1994-06-15
KR100266715B1 (ko) 2000-09-15
RU2125877C1 (ru) 1999-02-10
PH30702A (en) 1997-09-16
CN1041053C (zh) 1998-12-09
CA2102960A1 (fr) 1994-05-15
IL107454A (en) 1999-12-22
CA2504502A1 (fr) 1994-05-15
AU667243B2 (en) 1996-03-14
ATE143597T1 (de) 1996-10-15
EP0601345B1 (fr) 1996-10-02
NZ250103A (en) 1997-06-24
DZ1726A1 (fr) 2002-02-17
DE59304045D1 (de) 1996-11-07
AU5064393A (en) 1994-05-26
CN1092650A (zh) 1994-09-28
DE4238553A1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
PT79735A (de) 11beta-aryl-estradiene deren herstellung und diese enthaltende pharmazeutische praeparate
ATE146186T1 (de) Trifluormethylketon peptid derivate mit hle- inhibierende aktivität, deren herstellung und pharmazeutischen zusammensetzungen
MY115211A (en) Novel amino acid derivatives, their preparation and use
NO303926B1 (no) Anvendelse av imidazol-l-yl-forbindelser for fremstilling av farmas°ytiske preparater
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
MY113062A (en) Amide derivatives and their therapeutic use
RU93052161A (ru) Лекарственные средства, содержащие производные имидазол-1-ила
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE260655T1 (de) Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
NO950177D0 (no) Farmakologisk aktive erivater
TR199900013T2 (xx) Yeni bile�ikler.
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
DE69419083D1 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TH32887A (th) สารประกอบทางเคมี

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees